Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01575860
What this trial is testing

Maintenance Lenalidomide in Lymphoma

Who this might be right for
Lymphoma
Abramson Cancer Center at Penn Medicine 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT02782546
What this trial is testing

Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia
Washington University School of Medicine 60
Testing effectiveness (Phase 2)UnknownNCT01374841
What this trial is testing

Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

Who this might be right for
Hematologic Neoplasms
European Institute of Oncology 20
Testing effectiveness (Phase 2)Study completedNCT04943757
What this trial is testing

Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies

Who this might be right for
Myeloid Leukemia, AcuteChronic Myeloid LeukemiaMyelodysplastic Syndromes+1 more
St. Petersburg State Pavlov Medical University 50
Testing effectiveness (Phase 2)Study completedNCT00003877
What this trial is testing

Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Roswell Park Cancer Institute 30
Not applicableUnknownNCT06143501
What this trial is testing

Alterations in Intestinal Microbiota, Metabolites, and Immune Cells in Allo-HSCT

Who this might be right for
Graft Vs Host Disease
The First Affiliated Hospital of Soochow University 250
Testing effectiveness (Phase 2)UnknownNCT03540849
What this trial is testing

BV After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hodgkin Lymphoma
University Hospital, Caen 58
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Early research (Phase 1)Study completedNCT01917708
What this trial is testing

Bone Marrow Transplant With Abatacept for Non-Malignant Diseases

Who this might be right for
Hurler SyndromeFanconi AnemiaGlanzmann Thrombasthenia+12 more
Emory University 10
Testing effectiveness (Phase 2)Study completedNCT03491215
What this trial is testing

Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease

Who this might be right for
Acute Graft Versus Host Disease
Novartis Pharmaceuticals 45
Large-scale testing (Phase 3)Study completedNCT01041638
What this trial is testing

Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma

Who this might be right for
High Risk Neuroblastoma
National Cancer Institute (NCI) 105
Large-scale testing (Phase 3)Study completedNCT03959241
What this trial is testing

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

Who this might be right for
Acute LeukemiaChronic Myelogenous Leukemia (CML)Myelodysplasia+1 more
Medical College of Wisconsin 431
Not applicableUnknownNCT01714557
What this trial is testing

Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation

Who this might be right for
NeutropeniaHematopoietic Stem Cell Transplantation
Chinese PLA General Hospital 150
Large-scale testing (Phase 3)Looking for participantsNCT06294691
What this trial is testing

Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases

Who this might be right for
Acute Graft-versus-host Disease
Anhui Provincial Hospital 198
Early research (Phase 1)Study completedNCT03383055
What this trial is testing

CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig

Who this might be right for
LymphomaMultiple Myeloma
Masonic Cancer Center, University of Minnesota 28
Large-scale testing (Phase 3)Study completedNCT03930615
What this trial is testing

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

Who this might be right for
Cytomegalovirus Infection
Merck Sharp & Dohme LLC 220
Testing effectiveness (Phase 2)Ended earlyNCT03709576
What this trial is testing

Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Milton S. Hershey Medical Center 3
Testing effectiveness (Phase 2)Study completedNCT02248597
What this trial is testing

Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases

Who this might be right for
Graft Versus Host DiseaseHematopoietic/Lymphoid Cancer
Wake Forest University Health Sciences 27
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06931613
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaChildrenNivolumab+1 more
St. Petersburg State Pavlov Medical University 20
Testing effectiveness (Phase 2)Study completedNCT01883362
What this trial is testing

Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 60
Next Page